OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 16, 2020
The new facility at the company’s San Diego, CA, site will be for late phase and commercial CGMP manufacturing.
October 15, 2020
Cytiva will provide the first FlexFactory to be used in the manufacture of pDNA to Akron Bio.
September 14, 2020
The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.
September 09, 2020
The company is investing $130 million to add Phase III through commercial-scale manufacturing suites to its gene therapy campus in Harmans, MD.
September 02, 2020
The increased use of single-use bags in biologic manufacturing poses the risk of pinholes and other defects that cannot currently be tested for.
September 01, 2020
As technology matures, inefficiencies and process limitations in downstream process chromatography are improved.
August 13, 2020
The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.
August 01, 2020
It is critical to evaluate specific considerations, from design to application, for the benefit of downstream bioprocessing and manufacturing.
May 18, 2020
Ori Biotech is partnering with manufacturers and materials suppliers to develop an automated system for cell and gene therapy manufacturing.
May 01, 2020
Pumps and other components meet the demands of single-use systems in biopharmaceutical downstream processing.